These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 36992279)
1. The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development. Kozak M; Hu J Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992279 [TBL] [Abstract][Full Text] [Related]
2. The use of viral vectors in vaccine development. Travieso T; Li J; Mahesh S; Mello JDFRE; Blasi M NPJ Vaccines; 2022 Jul; 7(1):75. PubMed ID: 35787629 [TBL] [Abstract][Full Text] [Related]
3. Modes of Action for Mucosal Vaccine Adjuvants. Aoshi T Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755 [TBL] [Abstract][Full Text] [Related]
4. The next generation of HCV vaccines: a focus on novel adjuvant development. Kardani K; Sadat SM; Kardani M; Bolhassani A Expert Rev Vaccines; 2021 Jul; 20(7):839-855. PubMed ID: 34114513 [TBL] [Abstract][Full Text] [Related]
5. Intranasal and sublingual delivery of inactivated polio vaccine. Kraan H; Soema P; Amorij JP; Kersten G Vaccine; 2017 May; 35(20):2647-2653. PubMed ID: 28400164 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of live vaccines by co-delivery of immune modulating proteins. Manohar MM; Campbell BE; Walduck AK; Moore RJ Vaccine; 2022 Sep; 40(40):5769-5780. PubMed ID: 36064671 [TBL] [Abstract][Full Text] [Related]
8. Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms. Wilson-Welder JH; Boggiatto P; Nally JE; Wafa EI; Alt DP; Hornsby RL; Frank A; Jones DE; Olsen SC; Bowden NB; Salem AK Vaccine; 2020 Apr; 38(18):3464-3473. PubMed ID: 32204939 [TBL] [Abstract][Full Text] [Related]
9. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes. Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267 [TBL] [Abstract][Full Text] [Related]
10. Potentials of saponins-based adjuvants for nasal vaccines. Chen K; Wang N; Zhang X; Wang M; Liu Y; Shi Y Front Immunol; 2023; 14():1153042. PubMed ID: 37020548 [TBL] [Abstract][Full Text] [Related]
11. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines. Jin Z; Gao S; Cui X; Sun D; Zhao K Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213 [TBL] [Abstract][Full Text] [Related]
13. Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators. Tandrup Schmidt S; Foged C; Korsholm KS; Rades T; Christensen D Pharmaceutics; 2016 Mar; 8(1):. PubMed ID: 26978390 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity. Martins KAO; Cooper CL; Stronsky SM; Norris SLW; Kwilas SA; Steffens JT; Benko JG; van Tongeren SA; Bavari S EBioMedicine; 2016 Jan; 3():67-78. PubMed ID: 26870818 [TBL] [Abstract][Full Text] [Related]
15. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine. Zuckermann FA; Martin S; Husmann RJ; Brandt J Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035 [TBL] [Abstract][Full Text] [Related]